Matthew Doctor's most recent trade in Regis Corp. was a trade of 16,500 Common Stock done . Disclosure was reported to the exchange on Nov. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regis Corp. | Matthew Doctor | Director, President and CEO | 22 Nov 2024 | 16,500 | 19,584 (0%) | 0% | 0 | Common Stock | ||
| Regis Corp. | Matthew Doctor | Director, President and CEO | 05 Nov 2024 | 547 | 3,084 (0%) | 0% | 23.4 | 12,783 | Common Stock | |
| Regis Corp. | Matthew Doctor | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.37 per share. | 05 Nov 2024 | 339 | 3,292 (0%) | 0% | 23.4 | 7,922 | Common Stock |
| Regis Corp. | Matthew Doctor | Director, President and CEO | 06 Nov 2023 | 3,648 | 76,882 (0%) | 0% | 0.5 | 1,933 | Common Stock | |
| Regis Corp. | Matthew Doctor | Director, President and CEO | 07 Nov 2022 | 2,837 | 80,530 (0%) | 0% | 1.3 | 3,575 | Common Stock | |
| Regis Corp. | Matthew Doctor | Director, CEO | 05 May 2022 | 875,000 | 875,000 | - | - | Stock Options | ||
| Regis Corp. | Matthew Doctor | Interim CEO | 08 Feb 2022 | 4,343 | 83,367 (0%) | 0% | 1.7 | 7,166 | Common Stock | |
| Regis Corp. | Matthew Doctor | EVP, Chief Strategy Officer | 05 Nov 2021 | 46,344 | 87,710 (0%) | 0% | 0 | Common Stock | ||
| Regis Corp. | Matthew Doctor | EVP, Chief Strategy Officer | 08 Feb 2021 | 28,382 | 29,132 (0%) | 0% | 0 | Common Stock |